Compare Cassava Sciences Inc (FLNA) vs Lululemon Athletica Inc (LULU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Lululemon Athletica Inc — how do they compare? Cassava Sciences Inc trades at $1.1 (market cap $53.14M), while Lululemon Athletica Inc trades at $118.22 (market cap $13.33B). The key difference: Lululemon Athletica Inc is far larger — about 250.8× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.
| FLNA | LULU | |
|---|---|---|
Market Cap | $53.14M | $13.33B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $233.31 |
52-Week Low | $1.09 | $105.43 |
Enterprise Value | -$33.43M | $13.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Lululemon trades at $119.05, up 1.47% with neutral technical indicators and mixed sentiment. The stock shows strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.69 beating expectations of $1.67. Revenue grew to $10.59B in 2025 with robust profitability metrics including 55.7% gross margin and 32.03% ROE. Recent developments include a $30M investment in nylon recycling startup Syntetica and resolution of board disputes with founder Chip Wilson.
The outlook remains cautiously optimistic with a consensus price target of $129.29 offering 8.6% upside potential. Key opportunities include strong brand positioning and consistent execution, while risks involve competitive pressures and recent controversies affecting consumer trust. Analyst consensus leans neutral with 40.85% buy ratings versus 53.52% hold recommendations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Lululemon Athletica Inc
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →
